# A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

Source: https://onco.cc/trials/nct06474455/  
OnCo record `nct06474455` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of SHR-A1921, SHR-A2009, Aumolertinib, Pemetrexed, Carboplatin and Adebrelimab in advanced solid tumours, run by Shanghai Hengrui Pharmaceutical Co., Ltd., now recruiting.

## Summary

A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT06474455 by Shanghai Hengrui Pharmaceutical Co., Ltd., with 156 participants planned, started 2024-07-02 and due to reach its primary completion in 2029-06. Interventions recorded: SHR-9839 for Injection, SHR-A1921 for Injection, SHR-A2009 for Injection, Almonertinib Mesilate Tablets, Pemetrexed Disodium for Injection and Carboplatin for injection.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06474455
- Phase: 1/2
- Setting: A Phase IB/II, Open-Label, Multicentre Clinical Study to Evaluate the Safety, Tolerability and Efficacy of SHR-9839 for Injection in Combination With Other Therapies in Patients With Advanced Solid Tumors
- Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.
- Enrolled: 156

## Sources

- ClinicalTrials.gov NCT06474455: https://clinicaltrials.gov/study/NCT06474455

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- drugs: [Adebrelimab](https://onco.cc/drugs/adebrelimab/), [Aumolertinib](https://onco.cc/drugs/aumolertinib/), [Carboplatin](https://onco.cc/drugs/carboplatin/), [Pemetrexed](https://onco.cc/drugs/pemetrexed/), [SHR-A1921](https://onco.cc/drugs/shr-a1921/), [SHR-A2009](https://onco.cc/drugs/shr-a2009/)
- companies: [Jiangsu Hengrui Pharmaceuticals](https://onco.cc/companies/hengrui/)

---
JSON: https://onco.cc/api/v1/entities/nct06474455.json